CM313(SC) Injection

CM313 · Keymed Biosciences Co.Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CM313(SC) Injection, covering 2025-01-24 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness [Phase 1, Phase 2]